How to Apply to Legend Biotech

Key Takeaways

Legend Biotech is a NASDAQ-listed (LEGN), commercial-stage cell therapy company, ~36% owned by Hong Kong-listed Chinese parent GenScript, with U.S. headquarters in Somerset/Raritan NJ and a Belgian manufacturing site in Ghent.
Carvykti (cilta-cel), partnered globally with Johnson & Johnson's Janssen unit, is the flagship product. The 2017 partnership brought $350M upfront plus profit share; product run-rate is now $1.8B+ annually.
The applicant tracking system is Greenhouse, hosted at boards.greenhouse.io/legendcareers (the 'legendbiotech' token does not work).
Hiring is concentrated in CMC manufacturing (Raritan NJ), R&D and translational (Somerset NJ + Nanjing), clinical operations, regulatory affairs, and commercial roles supporting the J&J co-promotion.
Interview loops are 4 to 5 rounds, scientifically serious for R&D, GMP-pragmatic for manufacturing, and partnership-savvy for commercial. Expect a technical or scientific deep-dive in addition to behavioral interviews.
Be prepared to discuss the GenScript ownership, the J&J alliance, and the periodically-reported potential China R&D spin-off honestly. Trying to avoid these topics signals lack of preparation or political naivety.
Compensation includes base, target bonus (10-25%), and RSU equity. Negotiation is expected, particularly on equity and sign-on for candidates leaving competing offers.

About Legend Biotech

Legend Biotech Corporation (NASDAQ: LEGN) is a global, commercial-stage biotechnology company developing and manufacturing chimeric antigen receptor T-cell (CAR-T) therapies, with one of the most consequential cell therapy launches of the decade under its belt. The company was founded in 2014 as a subsidiary of GenScript Biotech, a Hong Kong-listed life sciences contract research organization headquartered in Nanjing, China, and was spun out as an independent public company through a NASDAQ IPO in June 2020. GenScript continues to hold roughly a 36% ownership stake post-spin and remains the company's largest shareholder, a relationship that gives Legend deep R&D ties to China while its commercial center of gravity has shifted firmly to the United States and Europe. Legend's flagship product is Carvykti (ciltacabtagene autoleucel, cilta-cel), a B-cell maturation antigen (BCMA)-targeted autologous CAR-T therapy approved for adults with relapsed or refractory multiple myeloma. Carvykti was discovered and developed by Legend Biotech and is co-developed and commercialized through a global strategic collaboration with Janssen Biotech, a Johnson & Johnson company. The 2017 deal brought Legend a $350 million upfront payment, contingent milestones, and a tiered profit-share arrangement that continues to shape both companies' multiple myeloma franchises today. Carvykti received its first U.S. FDA approval in February 2022, followed by European Commission approval in May 2022, and an expanded second-line label approval in 2024 that materially enlarged its addressable patient population. Net trade sales have grown rapidly, with the J&J-Legend partnership reporting an annualized run-rate well above $1.8 billion as of late 2025, and the partners have publicly targeted multibillion-dollar peak sales as supply scales. The company employs approximately 3,000 people globally and operates from three primary geographic anchors. United States operations are split across Somerset, New Jersey (corporate and commercial headquarters), Raritan, New Jersey (CMC manufacturing facility producing Carvykti for North American patients), and a Philadelphia-area presence supporting clinical and translational work. European manufacturing is centered in Ghent, Belgium, where Legend operates a dedicated Carvykti production plant that supplies EU patients and is undergoing capacity expansion to meet demand. The China R&D engine remains in Nanjing, where the original cilta-cel construct was invented and where most preclinical and discovery work, including next-generation solid tumor CAR-T candidates, continues today. Legend is led by Chief Executive Officer Ying Huang, PhD, who took the helm in 2022 after serving as the company's Chief Financial Officer. Huang holds a doctorate in chemistry from the University of California, Berkeley, brings prior experience as a senior biotech analyst at Bank of America Merrill Lynch, and represents the company's strategic shift toward operating as a fully integrated, U.S.-centered commercial biopharma rather than a discovery-stage Chinese affiliate. The board includes representatives reflecting both the GenScript heritage and an increasingly independent, internationally recruited leadership cohort. The pipeline beyond Carvykti is the long-term thesis investors and prospective employees are watching. Programs in development include LB1908, an autologous Claudin 18.2-targeted CAR-T for gastric and pancreatic cancers; LB2102, a DLL3-targeted CAR-T for small cell lung cancer; and a growing platform of allogeneic (off-the-shelf) cell therapy candidates intended to overcome the cost, timing, and scalability constraints of autologous manufacturing. Most of these constructs originate from GenScript-affiliated discovery work and are then advanced through Legend's translational and clinical organizations. A structural conversation that any candidate should be aware of is the periodically reported potential separation or partial spin-off of Legend's China-based assets. As of early 2026, multiple media outlets have reported that Legend has explored carving out its Chinese R&D operations into a separately financed entity, partly in response to U.S. legislative scrutiny of biotech ties to Chinese parent companies (notably the BIOSECURE Act discussions of 2024). No definitive transaction has been announced, but the geopolitical context is part of the lived reality of working at Legend, particularly for roles touching IP, manufacturing supply chain, or government affairs. For a job seeker, what makes Legend distinctive is the combination of pre-revenue science culture (most of the pipeline is early-stage) with the operational discipline of a commercial-stage company executing one of the most complex biologic launches in oncology. Carvykti is not a small molecule that can be made and shipped on demand. It is a personalized therapy made from each patient's own T-cells, requiring a vein-to-vein logistics chain measured in weeks, GMP cleanroom capacity, viral vector supply, and tight coordination with treating centers. People who join Legend are joining a company where manufacturing is the strategic moat, science is the long-term growth engine, and the J&J partnership underwrites the commercial runway.

Application Process

1
Step 1
Step 1 — Find the role on Legend's U.S. careers site at legendbiotech.com/careers, which lists openings filtered by department (Manufacturing, Quality, Research & Development, Clinical, Commercial, Finance, IT, Engineering & Facilities) and location (Somerset NJ, Raritan NJ, Bridgewater NJ, Philadelphia, plus remote U.S. roles). EU-based roles are routed to a separate site at legendbiotech.eu. Apply links forward to Legend's Greenhouse-hosted job board at boards.greenhouse.io/legendcareers (the token is 'legendcareers,' not 'legendbiotech').
2
Step 2
Step 2 — Create a Greenhouse application profile. Greenhouse accepts a resume upload (PDF or .docx are both safe) and parses it into structured fields, then asks you to confirm or edit the extracted contact, education, and work history blocks. You will also fill in EEO/voluntary self-identification questions, which are submitted to Legend in aggregate only and are not visible to the hiring team during evaluation.
3
Step 3
Step 3 — Complete the Legend-specific custom questions on the application form. These commonly include U.S. work authorization (Legend sponsors visas selectively for scientific roles but most manufacturing and commercial postings are restricted to candidates already authorized to work in the U.S. without sponsorship), willingness to relocate or commute to Raritan/Somerset, salary expectations, and one or two short essay prompts about your interest in cell therapy or in Legend specifically.
4
Step 4
Step 4 — Submit and expect an initial screening within 1 to 3 weeks. Talent acquisition partners (in-house, with some specialty recruiting partners for niche roles like viral vector process development) review applications. For high-volume manufacturing technician roles in Raritan, screening can be faster — sometimes within days. For senior R&D and director-and-above roles, the queue is longer because each requisition is reviewed by both the hiring manager and a second leader.
5
Step 5
Step 5 — Phone screen with a recruiter (30 minutes). The recruiter will confirm logistics (compensation range, location, work authorization), walk through your background, and assess basic culture fit. They will also explain Legend's relationship with J&J and the GenScript parent structure, which is information you should be able to discuss intelligently when it comes up.
6
Step 6
Step 6 — Hiring manager interview (45 to 60 minutes). For technical roles this is a deep dive into your relevant project history, scientific or operational reasoning, and your understanding of cell therapy specifically. Expect questions about CGMP, autologous vs. allogeneic platforms, BCMA biology, or whatever subdiscipline matches the role.
7
Step 7
Step 7 — Panel or loop interviews (typically 3 to 5 sessions, 45 minutes each). These can run as a single onsite/virtual loop or as separate scheduled interviews over 1 to 2 weeks. Panels typically include cross-functional partners (e.g., for an MSAT role, you would meet QC, Manufacturing, Process Development, and Regulatory), at least one peer, and sometimes a skip-level leader.
8
Step 8
Step 8 — Scientific or technical exercise where applicable. R&D roles often include a journal club style presentation (you select a recent paper and walk the panel through it, then answer probing questions) or a 'present your past work' deck. CMC and analytical roles may include a problem-solving case based on a real manufacturing deviation. Commercial roles typically include a market access or launch-readiness scenario.
9
Step 9
Step 9 — References, background check, and offer. Legend conducts standard pre-employment background checks (criminal, employment verification, education verification) through a third-party vendor. Expect a written offer with base salary, target bonus (typically 10 to 25% depending on level), restricted stock unit (RSU) grant, and benefits summary. Negotiation is expected and accepted, particularly on RSU equity and sign-on bonus for candidates leaving competing offers.
10
Step 10
Step 10 — Onboarding. New hires complete pre-employment paperwork through Greenhouse Onboard or Workday HCM. For Raritan manufacturing roles, expect site-specific GMP training, gowning qualification, and SOP read-and-understand sign-offs in the first 30 days. Corporate hires in Somerset go through a multi-day orientation that includes an overview of Carvykti, the J&J partnership, and Legend's pipeline.

Resume Tips for Legend Biotech

recommended

Lead with cell therapy or biologics keywords if you have them

Lead with cell therapy or biologics keywords if you have them. CAR-T, autologous, allogeneic, viral vector, lentivirus, leukapheresis, cryopreservation, BCMA, CD3/CD28, T-cell expansion, CGT (cell and gene therapy), advanced therapy medicinal products (ATMP), and 21 CFR Part 1271 are all terms Legend recruiters and Greenhouse keyword filters look for. If you have any adjacent experience (mAb manufacturing, vaccine fill-finish, gene therapy), make sure it is searchable in the resume body — not buried in a project description.

recommended

Quantify GMP and regulatory experience explicitly

Quantify GMP and regulatory experience explicitly. 'Authored 12 deviation investigations under FDA 21 CFR 211' lands harder than 'experience with deviations.' For R&D applicants, cite assay sensitivity, throughput, or characterization metrics ('developed flow cytometry panel detecting CAR+ cells at 0.01% sensitivity'). For clinical operations, name the protocol phase, indication, and your specific role (e.g., 'CRA on Phase 2 BCMA CAR-T trial, 14 sites across U.S. and EU').

recommended

Make J&J or partnership experience visible if you have it

Make J&J or partnership experience visible if you have it. Legend operates Carvykti through a deep co-commercialization with Janssen, so familiarity with how big pharma launches work — co-promote agreements, joint steering committees, transfer pricing, IDN account management — is a meaningful differentiator. If you have worked at J&J, Janssen, Bristol Myers Squibb (Breyanzi/Abecma), Gilead/Kite (Yescarta/Tecartus), or Novartis (Kymriah), name those programs by code or brand to make the relevance unmistakable.

recommended

For Raritan manufacturing roles, lead with cleanroom classification and shift ex

For Raritan manufacturing roles, lead with cleanroom classification and shift experience. ISO 5/Class 100, ISO 7/Class 10,000, BSL-2 viral vector handling, aseptic processing, and rotating shift availability are practical screening filters. Manufacturing supervisor candidates should specifically call out span of control (number of direct reports), batch record review experience, and any prior cell therapy facility startup experience.

recommended

For R&D roles based on the Legend U

For R&D roles based on the Legend U.S. side, frame yourself as translational rather than purely discovery. Discovery sits primarily in the Nanjing organization. U.S.-based scientific hires tend to be in translational research, MSAT (manufacturing science and technology), analytical development, process development, and regulatory CMC. Your resume should show movement from bench science toward IND-enabling, GMP transfer, or regulatory filing work.

recommended

Use a single-column, ATS-friendly format

Use a single-column, ATS-friendly format. Greenhouse parses well-structured resumes reliably, but stumbles on multi-column layouts, embedded text boxes, headers/footers with critical content, and non-standard section headings. Use 'Experience,' 'Education,' 'Skills,' and 'Certifications' as section labels. Save as PDF unless the job posting specifies .docx.

recommended

Be honest about geography

Be honest about geography. If you are not local to central New Jersey and the role is on-site in Raritan or Somerset, address it directly in your cover letter. Legend's manufacturing and commercial leadership prefer candidates already in or willing to commit to relocating to the New Jersey corridor. Vague language about 'open to relocation' that is contradicted by your address often results in early rejection.

ATS System: Greenhouse

Legend Biotech uses Greenhouse Recruiting as its applicant tracking system. The U.S. job board is hosted at boards.greenhouse.io/legendcareers (the company's Greenhouse token is 'legendcareers' rather than the more obvious 'legendbiotech,' which 404s — a useful detail if you are searching boards directly). Greenhouse is the modern, structured-hiring ATS used by most well-funded biotechs and tech-forward life sciences companies. It enforces consistent interview kits, scorecards, and structured candidate evaluation, which generally produces faster, more standardized decisions than legacy systems. EU-based positions are listed on a separate Legend EU careers site that may use a different ATS instance; if you are applying to Belgium or other European roles, start at legendbiotech.eu rather than the U.S. board.

Apply directly through boards.greenhouse.io/legendcareers or via the company careers site (which redirects to Greenhouse). Avoid third-party aggregators where possible — they sometimes rehost roles with stale links or expired requisition IDs.
Greenhouse parses PDFs and .docx files reliably. Avoid scanned PDFs, image-based resumes, or PDFs with unusual fonts that don't embed cleanly.
Fill in every field of the application form, even the ones marked optional. Greenhouse hiring teams configure custom screening questions intentionally, and partial responses can flag your application for lower-priority review.
If you withdraw and reapply later, Greenhouse retains your prior application and notes. Avoid creating multiple accounts with different email addresses — this fragments your record and can look unprofessional to recruiters who notice it.
Once submitted, Greenhouse sends an automated confirmation. Genuine interview invitations come from a Legend Biotech (@legendbiotech.com) email address or directly from the Greenhouse system. Be alert for cell-therapy-themed phishing scams that have impersonated Legend recruiters in the past.

Interview Culture

Legend Biotech's interview culture is best described as scientifically serious, operationally pragmatic, and increasingly process-disciplined as the company has scaled from a clinical-stage startup into a commercial-stage launch organization. Across every functional area, candidates report that the interview loop is designed to test whether you can do the actual work, not just talk about it. For R&D and translational roles, expect deep scientific scrutiny. Hiring managers at the director and senior scientist level often hold advanced degrees from strong programs, and they will probe both breadth (do you understand CAR-T biology beyond your own bench work?) and depth (can you defend the specific methods choices you made in your most recent project?). A common pattern is a journal club or 'chalk talk' style session where you present a paper or a past project and walk the panel through your reasoning under questioning. The bar is closer to academia than to legacy pharma: candidates with strong fundamentals and intellectual humility do well; candidates who oversell or paper over methodological gaps tend to be filtered out. For CMC, manufacturing, and quality roles in Raritan, the tone shifts toward execution rigor. Interviews emphasize CGMP compliance, deviation handling, change control, batch disposition, and the practical realities of running an autologous cell therapy line where every batch is one patient. Expect behavioral questions framed around real situations: tell me about a time you had to escalate a CAPA on a deadline, walk me through your worst deviation investigation, how would you handle a viable count failure during a Carvykti production run. Hiring managers want to know that you have lived these problems, not just read about them. For commercial, market access, and field-based medical roles, the loop emphasizes account knowledge, payer dynamics in cell therapy reimbursement, and the operational complexity of getting Carvykti from a treating center's apheresis procedure through manufacturing and back to infusion. Account managers are expected to understand the certified treatment center network, the role of NCCN guidelines, and the specifics of how the J&J co-promote arrangement plays out in the field. Culturally, Legend is in the middle of a transition. The early company was a small, scientifically-driven group with strong ties to GenScript's Nanjing R&D culture. The post-2022 commercial phase has rapidly added talent from J&J, Bristol Myers Squibb, Novartis, Kite, and other large-cap biopharma, which has imported a more structured, process-heavy operating style. Candidates report a workplace that values long hours and ownership during launch surges and capacity expansions, balanced against a leadership team that has been deliberate about building durable HR infrastructure rather than running on burnout. Remote and hybrid arrangements exist but are role-dependent — manufacturing, quality, and most R&D roles are on-site by necessity, while commercial, IT, finance, and corporate roles are more flexible. Diversity of background is increasing but is not yet at parity with peer commercial-stage biotechs. The leadership team has visible Chinese-American representation reflecting the GenScript heritage, plus growing recruitment from established U.S. biopharma. Candidates who can speak to working in cross-cultural, cross-time-zone organizations (the U.S.-China-Belgium triangle is a daily operational reality) tend to land well.

What Legend Biotech Looks For

Cell therapy domain knowledge — CAR-T mechanism, autologous vs. allogeneic trade-offs, BCMA biology, leukapheresis-to-infusion logistics. Legend hires candidates who already speak the language; ramp-up time is short because the organization is in commercial execution mode.
GMP and regulatory rigor for any role touching the product. FDA 21 CFR Parts 210/211/600/610/1271, EMA ATMP regulations, ICH Q-series guidance, and PIC/S documentation are baseline expectations for CMC, quality, and regulatory hires.
Operational execution under launch pressure. Legend is scaling Carvykti supply against unmet patient demand. Candidates who have lived through a commercial launch ramp — and can talk credibly about deviation reduction, throughput improvement, or capacity expansion — are in high demand.
Comfort with partnership operating models. Carvykti is co-developed and co-commercialized with Janssen. Roles that interface with the partnership require political maturity, governance literacy (joint steering committees, alliance management), and the patience to operate across two organizations' systems.
Cross-cultural fluency. The U.S.-Belgium-China operating footprint means most senior individual contributors and people leaders work across at least two of those geographies. Candidates with prior experience navigating Chinese biopharma, European ATMP regulators, or Asia-U.S. tech transfer cycles have an edge.
Pipeline curiosity. While Carvykti is the revenue engine, the next solid-tumor CAR-T programs are the long-term thesis. Candidates who can speak to where the field is heading — TCR therapies, allogeneic platforms, CRISPR-edited cells, in vivo CAR-T — signal that they are joining for the trajectory, not just the current product.
Stability and judgment about the geopolitical context. The GenScript ownership and the periodic reports about a potential China spin-off are real and ongoing. Candidates who treat this as something to understand rather than something to be evasive about read as more thoughtful and senior.

Frequently Asked Questions

Is Legend Biotech a Chinese company or an American company?

Legend Biotech is a U.S.-listed Cayman Islands holding company with operating subsidiaries in the United States, Belgium, and China. It was founded in 2014 as a subsidiary of GenScript Biotech (Hong Kong-listed, headquartered in Nanjing, China) and was spun out via a NASDAQ IPO in 2020 (ticker: LEGN). GenScript retains roughly a 36% ownership stake. The CEO and most of the executive team are based in the United States, the commercial organization and primary manufacturing site for Carvykti are in New Jersey and Belgium, and the discovery R&D engine remains in Nanjing. Practically, it operates as an internationally headquartered biotech with deep Chinese R&D heritage and a U.S./European commercial center of gravity.

What is the relationship with Johnson & Johnson?

In December 2017, Legend Biotech and Janssen Biotech (a Johnson & Johnson company) signed a global collaboration and license agreement to develop, manufacture, and commercialize cilta-cel (now branded Carvykti). Legend received a $350 million upfront payment plus contingent milestones, and the two companies share development costs and profits on a tiered basis (broadly 50/50 in major markets, with higher Janssen share in specific territories). Janssen leads commercialization globally with Legend playing an active co-promotion role in the U.S. The partnership is structured around joint steering committees and alliance management — meaning that for many roles at Legend, day-to-day work involves coordinating with J&J counterparts.

Where is Legend Biotech hiring most aggressively right now?

Three concentrations stand out as of early 2026. First, CMC manufacturing in Raritan, New Jersey, where Legend continues to scale capacity for Carvykti supply to North American patients — manufacturing technicians, supervisors, MSAT, quality control, and quality assurance. Second, the Belgium plant in Ghent, scaling EU patient supply and undergoing capacity expansion. Third, R&D and clinical operations supporting the solid-tumor CAR-T pipeline (LB1908, LB2102) and allogeneic platform development. Commercial hiring continues at a steadier pace, focused on field-based medical, market access, and account management roles supporting the J&J co-promotion. Corporate functions in Somerset (finance, IT, legal, HR) hire steadily but in lower volume.

Does Legend sponsor work visas?

Legend selectively sponsors work visas, primarily for scientific and senior technical roles where candidates have specialized expertise that is difficult to source domestically. H-1B sponsorship is more common for R&D scientist, regulatory affairs, and select CMC roles. Manufacturing technician positions, most commercial roles, and entry-to-mid-level corporate functions are typically restricted to candidates who already hold U.S. work authorization without sponsorship. The application form will ask about sponsorship status; answer honestly, because visa-related misrepresentation discovered later is grounds for offer rescission or termination.

What ATS does Legend Biotech use?

Legend Biotech uses Greenhouse Recruiting, hosted at boards.greenhouse.io/legendcareers. (Note: the more intuitive 'legendbiotech' token returns a 404 — the actual board token is 'legendcareers'.) Greenhouse is a modern, structured-hiring ATS that supports clean PDF/.docx parsing, configurable interview kits, and scorecards. EU-based positions may live on a separate Legend EU careers site at legendbiotech.eu and use a different ATS instance, so apply through the regional site that matches the role's location.

Is the rumored China spin-off something I should worry about as a candidate?

It is something to understand, not something to fear. Multiple media outlets have reported throughout 2024 and 2025 that Legend has explored carving out its Chinese R&D operations into a separately financed entity, partly in response to U.S. legislative scrutiny of biotech ties to Chinese parent companies. As of early 2026, no definitive transaction has been announced, and the U.S.-based commercial, manufacturing, and translational organizations would likely continue operating under the existing Legend Biotech structure regardless of how a separation is ultimately structured. If you are interviewing for a U.S. or Belgium-based role, the practical impact is limited. If you are interviewing for a Nanjing-based R&D role, it is a fair question to raise during the interview loop and a reasonable hiring manager will engage with it candidly.

How long does the hiring process take?

End-to-end timelines vary by function. Manufacturing technician and operator roles in Raritan can move from application to offer in 2 to 4 weeks. Most professional and individual contributor roles run 4 to 8 weeks. Director and above hires often run 8 to 12 weeks because of additional executive interviews, broader stakeholder consensus, and competing priorities at the leadership level. Add another 1 to 3 weeks for background check, offer negotiation, and start date scheduling.

What does compensation look like at Legend?

Compensation is competitive with mid-cap commercial biotech peers (Bristol Myers Squibb cell therapy, Kite/Gilead, Novartis CAR-T) and is anchored in a base salary, target bonus, and equity grant structure. Bonus targets typically range from 10% at individual contributor levels to 20-25% at director level and higher at senior leadership. Equity is granted as restricted stock units (RSUs) tied to NASDAQ-listed LEGN stock, with multi-year vesting (typically 4-year vesting with a 1-year cliff). Sign-on bonuses are routine for candidates leaving competing offers. Negotiation is accepted; recruiters expect a reasonable counter and most offers have headroom on equity and sign-on, less on base.

Should I tailor my resume differently for Legend than for J&J or Bristol Myers Squibb?

Yes, in tone if not in substance. Legend is meaningfully smaller than J&J or BMS (~3,000 employees vs. tens of thousands), so highlighting the ability to work without large institutional support — wearing multiple hats, owning a process end-to-end, navigating ambiguity — lands well. The flip side: Legend is increasingly process-mature and operating in close partnership with J&J, so framing yourself as 'startup-only' is also a mismatch. The sweet spot is candidates who can demonstrate both ownership (small-company instincts) and process discipline (regulated-industry rigor).

How to Apply to Legend Biotech

Key Takeaways

About Legend Biotech

Application Process

Resume Tips for Legend Biotech

Lead with cell therapy or biologics keywords if you have them

Quantify GMP and regulatory experience explicitly

Make J&J or partnership experience visible if you have it

For Raritan manufacturing roles, lead with cleanroom classification and shift ex

For R&D roles based on the Legend U

Use a single-column, ATS-friendly format

Be honest about geography

ATS System: Greenhouse

Interview Culture

What Legend Biotech Looks For

Frequently Asked Questions

Open Positions

Related Resources

Similar Companies

Sources